Attention-Deficit/Hyperactivity Disorder Is Associated With Increased Rates of Childhood Infectious Diseases: A Population-Based Case-Control Study
- PMID: 36007815
- DOI: 10.1016/j.jaac.2022.06.018
Attention-Deficit/Hyperactivity Disorder Is Associated With Increased Rates of Childhood Infectious Diseases: A Population-Based Case-Control Study
Abstract
Objective: Infectious diseases (IDs) pose a heavy burden on children. An association between pediatric attention-deficit/hyperactivity disorder (ADHD) and specific IDs has been documented. Our objective was to test the possibility that ADHD is associated with increased likelihood for pediatric IDs at large.
Method: A population-based case-control study was conducted using Electronic Medical Records (EMRs) of a national Health Maintenance Organization, Leumit Health Services (LHS). ICD-9/10 criteria were used for all diagnoses. The study population consisted of all children and adolescents (aged 5-18 years), members of LHS between January 1, 2006-June 30, 2021. Case patients met International Classification of Diseases (ICD-9/10) criteria for ADHD. Controls included randomly selected persons without ADHD (2:1 ratio), matched individually by demographic indices. The EMRs retrieved 3 exposure categories: pediatric ID, anti-infective medications use, and number of physician visits. The study was approved by the review board of Shamir Medical Center and the Research Committee of LHS.
Results: Cases patients comprised 18,756 participants, with a mean age of 8.3 ± 2.6 years and a male/female ratio of 63%:37%. Matched controls comprised 37,512 participants, with a mean age of 8.3 ± 2.6 years and a male/female ratio of 63%:37%. Demographic variables were similar between the groups. The rates of all IDs were significantly higher in participants with ADHD than in controls and were not restricted to a single body system, including acute respiratory infection (OR = 1.4, 95% CI = 1.3-1.4, p < .001), acute gastroenteritis (OR = 1.3,95% CI 1.3-1.4, p < .001), salmonellosis (OR = 2.8, 95% CI = 2.3-3.5, p < .001), and urinary tract infection (OR = 1.3, 95% CI = 1.2-1.4, p < .001). All anti-infective agents were prescribed significantly more often to children with ADHD. There were significantly higher rates of physician visits for participants with ADHD.
Conclusion: Study findings suggest an association between ID and pediatric ADHD Health care providers should be aware of this potential association.
Clinical trial registration information: The Health and Economic Impact of Treated and Untreated ADHD; https://www.shamir.org/; 005-18-LEU.
Keywords: ADHD; infections; public health.
Copyright © 2022 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Childhood Attention-Deficit/Hyperactivity Disorder, Sex, and Obesity: A Longitudinal Population-Based Study.Mayo Clin Proc. 2016 Mar;91(3):352-61. doi: 10.1016/j.mayocp.2015.09.017. Epub 2016 Feb 4. Mayo Clin Proc. 2016. PMID: 26853710 Free PMC article.
-
The Association Between Repeated Measured Febrile Episodes During Early Childhood and Attention Deficit Hyperactivity Disorder: A Large-Scale Population-Based Study.J Atten Disord. 2024 Mar;28(5):677-685. doi: 10.1177/10870547231215289. Epub 2024 Jan 28. J Atten Disord. 2024. PMID: 38281128
-
Incontinence in children with treated attention-deficit/hyperactivity disorder.J Pediatr Urol. 2015 Jun;11(3):141.e1-6. doi: 10.1016/j.jpurol.2015.02.009. Epub 2015 Mar 12. J Pediatr Urol. 2015. PMID: 25863677
-
Association of Perinatal and Childhood Ischemic Stroke With Attention-Deficit/Hyperactivity Disorder.JAMA Netw Open. 2022 Apr 1;5(4):e228884. doi: 10.1001/jamanetworkopen.2022.8884. JAMA Netw Open. 2022. PMID: 35471571 Free PMC article.
-
Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.JAMA. 1998 Apr 8;279(14):1100-7. doi: 10.1001/jama.279.14.1100. JAMA. 1998. PMID: 9546570 Review.
Cited by
-
The Association between Glucose 6-Phosphate Dehydrogenase Deficiency and Attention Deficit/Hyperactivity Disorder.Nutrients. 2023 Nov 29;15(23):4948. doi: 10.3390/nu15234948. Nutrients. 2023. PMID: 38068806 Free PMC article.
-
Increased Prevalence of Attention Deficit Hyperactivity Disorder in Individuals with Selective Immunoglobulin A Deficiency: A Nationwide Case-Control Study.J Clin Med. 2024 Oct 12;13(20):6075. doi: 10.3390/jcm13206075. J Clin Med. 2024. PMID: 39458025 Free PMC article.
-
Genetic evidence for causal effects of immune dysfunction in psychiatric disorders: where are we?Transl Psychiatry. 2024 Jan 26;14(1):63. doi: 10.1038/s41398-024-02778-2. Transl Psychiatry. 2024. PMID: 38272880 Free PMC article. Review.
-
NDD-ECHO: A standardised digital assessment tool to capture early life environmental and inflammatory factors for children with neurodevelopmental disorders.Brain Behav Immun Health. 2025 May 8;46:101011. doi: 10.1016/j.bbih.2025.101011. eCollection 2025 Jul. Brain Behav Immun Health. 2025. PMID: 40485664 Free PMC article.
-
Increased prevalence of urticarial diseases and antihistamine/corticosteroid consumption in patients with attention-deficit/hyperactivity disorder.BMJ Ment Health. 2025 Apr 20;28(1):e301588. doi: 10.1136/bmjment-2025-301588. BMJ Ment Health. 2025. PMID: 40254334 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous